ArticlePloS one2019

Tumor growth suppression using a combination of taxol-based therapy and GSK3 inhibition in non-small cell lung cancer.

Linda O'Flaherty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.